Currently, there are 123.78M common shares owned by the public and among those 123.40M shares have been available to trade.
The company’s stock has a 5-day price change of -7.08% and -6.52% over the past three months. CLX shares are trading -8.74% year to date (YTD), with the 12-month market performance up to 0.11% higher. It has a 12-month low price of $127.60 and touched a high of $171.37 over the same period. CLX has an average intraday trading volume of 1.14 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -6.69%, -8.95%, and -2.23% respectively.
Institutional ownership of Clorox Co (NYSE: CLX) shares accounts for 80.06% of the company’s 123.78M shares outstanding.
It has a market capitalization of $18.35B and a beta (3y monthly) value of 0.44. The stock’s trailing 12-month PE ratio is 40.51, while the earnings-per-share (ttm) stands at $3.66. The company has a PEG of 5.42 and a Quick Ratio of 0.60. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.44% over the week and 1.85% over the month.
Earnings per share for the fiscal year are expected to increase by 14.73%, and 2.86% over the next financial year. EPS should grow at an annualized rate of 7.48% over the next five years, compared to -18.70% over the past 5-year period.
Looking at the support for the CLX, a number of firms have released research notes about the stock. Wells Fargo stated their Equal Weight rating for the stock in a research note on January 07, 2025, with the firm’s price target at $157. TD Cowen coverage for the Clorox Co (CLX) stock in a research note released on November 06, 2024 offered a Hold rating with a price target of $170. Jefferies was of a view on October 01, 2024 that the stock is Buy, while TD Cowen gave the stock Sell rating on July 23, 2024, issuing a price target of $122. Exane BNP Paribas on their part issued Underperform rating on June 24, 2024.
